Playback speed
10 seconds
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for 2L & Later Treatment of mTNBC"
By
Oncology Data Advisor
FEATURING
Kevin Kalinsky
By
Oncology Data Advisor
FEATURING
Kevin Kalinsky
0 views
November 7, 2023
Comments 0
Login to view comments.
Click here to Login